Adamis Pharma Volatility

ADMPDelisted Stock  USD 0.56  0.02  3.45%   
We have found twenty-nine technical indicators for Adamis Pharma, which you can use to evaluate the volatility of the firm. Please confirm Adamis Pharma's risk adjusted performance of 0.0112, and Mean Deviation of 9.67 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%. Key indicators related to Adamis Pharma's volatility include:
660 Days Market Risk
Chance Of Distress
660 Days Economic Sensitivity
Adamis Pharma Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Adamis daily returns, and it is calculated using variance and standard deviation. We also use Adamis's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Adamis Pharma volatility.
  
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Adamis Pharma can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Adamis Pharma at lower prices. For example, an investor can purchase Adamis stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Adamis Pharma's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Moving against Adamis Stock

  0.86GE GE Aerospace Earnings Call This WeekPairCorr
  0.84XOM Exxon Mobil Corp Earnings Call This WeekPairCorr
  0.8MDH MDH Acquisition CorpPairCorr
  0.78CE Celanese Financial Report 14th of May 2024 PairCorr
  0.76WMT Walmart Financial Report 16th of May 2024 PairCorr
  0.76JPM JPMorgan Chase Financial Report 12th of July 2024 PairCorr
  0.74DD Dupont De Nemours Report 7th of May 2024 PairCorr
  0.72DIS Walt Disney Report 8th of May 2024 PairCorr
  0.72AA Alcoa Corp Financial Report 17th of July 2024 PairCorr

Adamis Pharma Market Sensitivity And Downside Risk

Adamis Pharma's beta coefficient measures the volatility of Adamis stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Adamis stock's returns against your selected market. In other words, Adamis Pharma's beta of 0.16 provides an investor with an approximation of how much risk Adamis Pharma stock can potentially add to one of your existing portfolios. Adamis Pharma is showing large volatility of returns over the selected time horizon. Adamis Pharma is a potential penny stock. Although Adamis Pharma may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Adamis Pharma. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Adamis instrument if you perfectly time your entry and exit. However, remember that penny delisted stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze Adamis Pharma Demand Trend
Check current 90 days Adamis Pharma correlation with market (NYSE Composite)

Adamis Beta

    
  0.16  
Adamis standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  0.0  
It is essential to understand the difference between upside risk (as represented by Adamis Pharma's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Adamis Pharma's daily returns or price. Since the actual investment returns on holding a position in adamis stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Adamis Pharma.

Adamis Pharma Stock Volatility Analysis

Volatility refers to the frequency at which Adamis Pharma delisted stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Adamis Pharma's price changes. Investors will then calculate the volatility of Adamis Pharma's stock to predict their future moves. A delisted stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile delisted stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Adamis Pharma's volatility:

Historical Volatility

This type of delisted stock volatility measures Adamis Pharma's fluctuations based on previous trends. It's commonly used to predict Adamis Pharma's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Adamis Pharma's current market price. This means that the delisted stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Adamis Pharma's to be redeemed at a future date.
Transformation
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

Adamis Pharma Projected Return Density Against Market

Given the investment horizon of 90 days Adamis Pharma has a beta of 0.1639 . This suggests as returns on the market go up, Adamis Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Adamis Pharma will be expected to be much smaller as well.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Adamis Pharma or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Adamis Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Adamis delisted stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Adamis Pharma has an alpha of 0.0379, implying that it can generate a 0.0379 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Predicted Return Density   
       Returns  
Adamis Pharma's volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how adamis stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives an Adamis Pharma Price Volatility?

Several factors can influence a delisted stock's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Adamis Pharma Stock Return Volatility

Adamis Pharma historical daily return volatility represents how much of Adamis Pharma delisted stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The enterprise inherits 0.0% risk (volatility on return distribution) over the 90 days horizon. By contrast, NYSE Composite accepts 0.6179% volatility on return distribution over the 90 days horizon.
 Performance 
       Timeline  

About Adamis Pharma Volatility

Volatility is a rate at which the price of Adamis Pharma or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Adamis Pharma may increase or decrease. In other words, similar to Adamis's beta indicator, it measures the risk of Adamis Pharma and helps estimate the fluctuations that may happen in a short period of time. So if prices of Adamis Pharma fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California. Adamis Pharmaceuticl operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 15 people.
Adamis Pharma's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Adamis Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Adamis Pharma's price varies over time.

3 ways to utilize Adamis Pharma's volatility to invest better

Higher Adamis Pharma's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Adamis Pharma stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Adamis Pharma stock volatility can provide helpful information for making investment decisions in the following ways:
  • Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Adamis Pharma investment. A higher volatility means higher risk and potentially larger changes in value.
  • Identifying Opportunities: High volatility in Adamis Pharma's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
  • Diversification: Understanding how the volatility of Adamis Pharma's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Remember it's essential to remember that stock volatility is just one of many factors to consider when making investment decisions, and it should be used in conjunction with other fundamental and technical analysis tools.

Adamis Pharma Investment Opportunity

NYSE Composite has a standard deviation of returns of 0.62 and is 9.223372036854776E16 times more volatile than Adamis Pharma. 0 percent of all equities and portfolios are less risky than Adamis Pharma. You can use Adamis Pharma to protect your portfolios against small market fluctuations. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Adamis Pharma to be traded at $0.5376 in 90 days.

Adamis Pharma Additional Risk Indicators

The analysis of Adamis Pharma's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Adamis Pharma's investment and either accepting that risk or mitigating it. Along with some common measures of Adamis Pharma stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar delisted stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Adamis Pharma Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Adamis Pharma as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Adamis Pharma's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Adamis Pharma's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Adamis Pharma.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Consideration for investing in Adamis Stock

If you are still planning to invest in Adamis Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adamis Pharma's history and understand the potential risks before investing.
CEOs Directory
Screen CEOs from public companies around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Money Managers
Screen money managers from public funds and ETFs managed around the world
Transaction History
View history of all your transactions and understand their impact on performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets